Stay updated with breaking news from Orphan Products Grants Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced significantly improved financial results...
These measures follow the successful passage of H.R. 6833 in October, which included a five-year reauthorization of critical FDA user-fee programs that help ensure rare disease patients gain timely access to essential therapies and diagnostic tools.
SILVER SPRING, Md., Oct. 17, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it has awarded 19 new grants and two new contracts totaling more than $38
Research for rare diseases including ALS will be supported over the next four years by $38 million in FDA funding.
WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration has awarded 19 new grants and two new contracts totaling more than $38 million in funding mainly to develop medical products to treat